Titin M-line insertion sequence 7 is required for proper cardiac function in mice

Titin is a giant sarcomeric protein that is involved in a large number of functions, with a primary role in skeletal and cardiac sarcomere organization and stiffness. The titin gene (TTN) is subject to various alternative splicing events, but in the region that is present at the M-line, the only exo...

Full description

Saved in:
Bibliographic Details
Published inJournal of cell science Vol. 134; no. 18
Main Authors Biquand, Ariane, Spinozzi, Simone, Tonino, Paola, Cosette, Jérémie, Strom, Joshua, Elbeck, Zaher, Knöll, Ralph, Granzier, Henk, Lostal, William, Richard, Isabelle
Format Journal Article
LanguageEnglish
Published England Company of Biologists 15.09.2021
The Company of Biologists Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Titin is a giant sarcomeric protein that is involved in a large number of functions, with a primary role in skeletal and cardiac sarcomere organization and stiffness. The titin gene (TTN) is subject to various alternative splicing events, but in the region that is present at the M-line, the only exon that can be spliced out is Mex5, which encodes for the insertion sequence 7 (is7). Interestingly, in the heart, the majority of titin isoforms are Mex5+, suggesting a cardiac role for is7. Here, we performed comprehensive functional, histological, transcriptomic, microscopic and molecular analyses of a mouse model lacking the Ttn Mex5 exon (ΔMex5), and revealed that the absence of the is7 is causative for dilated cardiomyopathy. ΔMex5 mice showed altered cardiac function accompanied by increased fibrosis and ultrastructural alterations. Abnormal expression of excitation–contraction coupling proteins was also observed. The results reported here confirm the importance of the C-terminal region of titin in cardiac function and are the first to suggest a possible relationship between the is7 and excitation–contraction coupling. Finally, these findings give important insights for the identification of new targets in the treatment of titinopathies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Handling Editor: John Heath
ISSN:0021-9533
1477-9137
1477-9137
DOI:10.1242/jcs.258684